Skip to search formSkip to main contentSkip to account menu

T140 peptide

Known as: T140 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A dual modality 99mTc/Re(i)-labelled T140 analogue for imaging of CXCR4 expression.
The C-X-C chemokine receptor 4 (CXCR4) has been shown to be overexpressed in at least 23 types of cancer, including prostate… 
2012
2012
Pharmacophore-based small molecule CXCR4 ligands.
2012
2012
Will the Stroma-derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer?
See Article on Page 27-34 The chemokine stroma-derived factor (SDF-1α/CXCL12) is a homeostatic chemokine. The major function… 
2009
2009
Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site.
2009
2009
Inhibitory effect of newly developed CXC-chemokine receptor 4 antagonists on the infection with feline immunodeficiency virus.
CXC-chemokine receptor 4 (CXCR4) functions as a receptor for feline immunodeficiency virus (FIV). Although we previously found… 
2006
2006
The chemokine SDF-1alpha suppresses fibronectin-mediated in vitro lymphocytes adhesion.
Stromal cell-derived factor (SDF-1) is a CXC chemokine that selectively activates the CXCR4 chemokine receptor. Fibronectin is an… 
Highly Cited
2005
Highly Cited
2005
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
Prostate cancer has a predilection to metastasise to the bone marrow stroma (BMS) by an as yet uncharacterised mechanism. We have… 
2002
2002
Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study.
2001
2001
Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity.
2001
2001
Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134.
The chemokine receptors CXCR4 and CCR5 are considered to be potential targets for the inhibition of HIV-1 replication. We have… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)